English

More about this topic

United Kingdom

Oxford vaccine is safe and provokes response in adults over 56: study

Older people are at a disproportionate risk of severe COVID-19 disease, so it is essential that any vaccine adopted for use is effective in this group.

Europe News

Have our vaccine, if you can produce it, says Russia's EU ambassador

Hungary is the only country in the EU to trial Russia's Sputnik V coronavirus vaccine.

Europe News

MEPs want to see what's in EU's coronavirus vaccine contracts

They are concerned EU countries might have to pick up the tab if anything goes wrong with the vaccines.

USA

Our coronavirus vaccine is 90% effective, says Pfizer

"Today is a great day for science and humanity," Pfizer Chairman and CEO, Dr. Albert Bourla, said.

ADVERTISEMENT

World News

How close are we to finding a coronavirus vaccine?

After more than six months coronavirus was first identified, scientists are yet to announce a vaccine that will prevent the spread of the deadly disease. But with almost a dozen candidates in the clinical trial phase, hopes are growing for that a vaccine will be available soon.

Europe Decoded

Facebook to ban paid anti-vax ads but not posts

The latest policy is an extension of Facebook's rules that ban adverts about vaccine "hoaxes".

USA

Trump sees mass COVID-19 vaccinations 'soon', contradicting experts

The US President's claims fly in the face of evidence from health experts who say it could be months or longer before a vaccine is ready for mass distribution.

World News

Schinas promises 'affordable and equitable' access to COVID-19 vaccine

The vice president of the European Commission has reassured citizens that the rollout of a future coronavirus vaccine will be fair and well organised, and admitted the frustration felt within the EU executive at the chaos in healthcare at the beginning of the pandemic.

World News

Oxford University vaccine trial halted after participant falls ill

AstraZeneca, who is running the trials, is investigating whether the COVID-19 candidate vaccine recipient's "potentially unexplained” illness is a result of receiving the shot.

Russia

Russia's COVID-19 vaccine: Trial results 'encouraging but small'

A peer review of trials of the Sputnik V vaccine published in The Lancet reports promising results, but adds that more work is needed.

Europe News

Pharma companies aim to avoid lawsuits over corona vaccine

The pharmaceutical industry are preemptively looking to avoid lawsuits in the coronavirus vaccine race through their negotiations with the European Commission.

France

Macron: Coronavirus vaccine likely ready in 'coming months'

It comes after the EU secured 225 million doses of a potential COVID-19 vaccine by German company CureVac.

World News

Record flu vaccine doses produced to avert COVID-19 hospitals crisis

Authorities are hoping to reduce the number of flu patients in hospitals this winter amid fears of a COVID-19 rebound.

USA

US developing strain of coronavirus for future vaccine tests

The strain of coronavirus could one day be injected into volunteers to test whether experimental vaccines are effective.

World News

Which countries are best-placed for getting a COVID-19 vaccine?

37 vaccines are currently undergoing human trials worldwide.

Russia

Russia's COVID-19 vaccine 'more of a Molotov cocktail at this point'

Former FDA Associate Commissioner Peter Pitts says there are many questions behind the announcement by Vladimir Putin.

United Kingdom

COVID-19: Only 50% of Brits say they will definitely get vaccinated

Researchers found that respondents who are sceptical about science and authority are more likely to refuse the vaccine.

United Kingdom

Misinformation on social media is a 'threat' to coronavirus vaccine

Concern among doctors is growing over the spread of misinformation about vaccines on social media platforms.

World News

COVID-19: EU reserves 300 million doses of vaccines in Sanofi deal

Coronavirus: EU says it struck deal with Sanofi for 300 million doses of potential COVID-19 vaccine

USA

Largest test of experimental COVID-19 vaccine begins in the US

30,000 people are taking part across the country. Results aren't expected before November.